Daxor Corporation (DXR) News

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence Oak Ridge, TN, Oct. 09, 2024...

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE...

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood...

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management

Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE...

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee

The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job Creation Oak Ridge...

Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care

1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE...

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Form N-CSRS - Certified Shareholder Report, Semi-Annual

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network

Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN...

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

Form N-2 - Registration statement for closed-end investment companies

Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer

Oak Ridge, TN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...